Prostate Cancer - Results from #23300

ASCO 2013 - Slide Presentation: Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302 June 1, 2013

ASCO 2013 - Slide Lecture: Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302 June 1, 2013

ASCO 2013 - Podcast: Long-term safety and efficacy analysis of abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer without prior chemotherapy (COU-AA-302) June 1, 2013

Imaging treated prostate cancer - Abstract June 1, 2013

Multiparametric MRI of prostate cancer: An update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer - Abstract June 1, 2013

Evaluation of serum calcium as a predictor of biochemical recurrence following salvage radiation therapy for prostate cancer - Abstract June 1, 2013

Decision regret in men undergoing dose-escalated radiation therapy for prostate cancer - Abstract June 1, 2013

Socioeconomic variation and prostate specific antigen testing in the community: A UK- based population study - Abstract June 1, 2013

Ultrasound elastography of the prostate: State of the art - Abstract May 31, 2013

The role of prostate-specific antigen in light of new scientific evidence - Abstract May 31, 2013

Automatic prostate tracking and motion assessment in volumetric modulated arc therapy with an electronic portal imaging device - Abstract May 31, 2013

Targeting bone physiology for the treatment of metastatic prostate cancer - Abstract May 31, 2013

A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer - Abstract May 31, 2013

The dilemma of localizing disease relapse after radical treatment for prostate cancer: Which is the value of the actual imaging techniques? - Abstract May 30, 2013

Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: Long-term outcomes - Abstract May 30, 2013

Multiparametric magnetic resonance imaging of prostate cancer - Abstract May 30, 2013

The diagnostic value of conventional MRI in the differentiation of malignant tumor from benign lesion in prostatic peripheral zone - Abstract May 30, 2013

Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment - Abstract May 30, 2013

Focal brachytherapy for selected low-risk prostate cancers: A pilot study - Abstract May 30, 2013

Podcast: Castration-resistant prostate cancer: AUA Guideline 2013 commentary, by E. David Crawford, MD May 30, 2013

Page 1166 of 1447